PIK3CA mutation and methylation influences the outcome of colorectal cancer

Oncology Letters

Volumn 3, Issue 3, 2012, Pages 565-570

  Iida, Satoru ^a   Kato, Shunsuke ^a   Ishiguro, Megumi ^b   Matsuyama, Takatoshi ^a   Ishikawa, Toshiaki ^a   Kobayashi, Hirotoshi ^c   Higuchi, Tetsuro ^b   Uetake, Hiroyuki ^a   Enomoto, Masayuki ^a   Sugihara, Kenichi ^a  

^a Department of Surgical Oncology ^*  (Japan)

^b Graduate Education Program for Cancer Treatment Specialists   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

BNIP3; Colorectal cancer; Methylation; Mutation; PIK3CA

Indexed keywords

K RAS PROTEIN; PEPTIDES AND PROTEINS; PIK3CA PROTEIN; PROTEIN BNIP3; PROTEIN MLH1; PROTEIN P16; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GENETICS; CANCER PATIENT; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; EPIGENETICS; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METHYLATION; OUTCOME ASSESSMENT; PROGNOSIS; WILD TYPE;

EID: 84855678871     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.544     Document Type: Article

References (34)

1. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics. CA Cancer J Clin 60: 277-300, 2010.
2. Wood LD, Parsons DW, Jones S, et al: The genomic landscape of human breast and colorectal cancers. Science 318: 1108-1113, 2007.
3. Jones PA and Baylin SB: The fundamental role of epigenetic events in cancer. Nat Rev Genet 3: 415-428, 2002.
4. Jones PA and Baylin SB: The epigenomics of cancer. Cell 128: 683-692, 2007.
5. Iida S, Akiyama Y, Nakajima T, Ichikawa W, Nihei Z, SugiharaK, and Yuasa Y: Alterations and hypermethylation of the p14ARF gene in gastric cancer. Int J Cancer 87: 654-658, 2000.
6. Samuels Y, Wang Z, Bardelli A, et al: High frequency of mutations of the PIK3CA gene in human cancers. Science 304: 554, 2004.
7. Vogelstein B, Fearon ER, Hamilton SR, et al: Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525-532, 1988.
8. Kato S, Iida S, Higuchi T, et al: PIK3CA mutation is predictive of poor survival in patients with colorectal cancer. Int J Cancer 121: 1771-1778, 2007.
9. Eads CA, Danenberg KD, Kawakami K, et al: MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 28: E32-00, 2000.
10. Shimizu S, Iida S, Ishiguro M, et al: Methylated BNIP3 gene in colorectal cancer prognosis. Oncol Lett 1: 865-872, 2010.
11. Aoyagi H, Iida S, Uetake H, et al: Effect of classification based on combination of mutation and methylation in colorectal cancer prognosis. Oncol Rep 25: 789-794, 2011.
12. Ward RL, Cheong K, Ku SL, Meagher A, O'Connor T and Hawkins NJ: Adverse prognostic effect of methylation in colorectal cancer is reversed by microsatellite instability. J Clin Oncol 21: 3729-3736, 2003.
13. Shen L, Toyota M, Kondo Y, et al: Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc Natl Acad Sci USA 104: 18654-18659, 2007.
14. Reed JC: Bcl-2 family proteins. Oncogene 17: 3225-3236, 1998.
15. Labi V, Erlacher M, Kiessling S and Villunger A: BH3-only proteins in cell death initiation, malignant disease and anticancer therapy. Cell Death Differ 13: 1325-1338, 2006.
16. Strasser A: The role of BH3-only proteins in the immune system. Nat Rev Immunol 5: 189-200, 2005.
17. Willis SN and Adams JM: Life in the balance: how BH3-only proteins induce apoptosis. Curr Opin Cell Biol 17: 617-625, 2005.
18. Vande VC, Cizeau J, Dubik D, et al: BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol Cell Biol 20: 5454-5468, 2000.
19. Mellor HR and Harris AL: The role of the hypoxia-inducible BH3-only proteins BNIP3 and BNIP3L in cancer. Cancer Metastasis Rev 26: 553-566, 2007.
20. Murai M, Toyota M, Suzuki H, et al: Aberrant methylation and silencing of the BNIP3 gene in colorectal cancer and gastric cancer. Clin Cancer Res 11: 1021-1027, 2005.
21. Akada M, Crnogorac-Jurcevic T, Lattimore S, et al: Intrinsic chemoresistance to gemcitabine is associated with decreased expression of BNIP3 in pancreatic cancer. Clin Cancer Res 11: 3094-3101, 2005.
22. Erkan M, Kleeff J, Esposito I, et al: Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis. Oncogene 24: 4421-4432, 2005.
23. Manka D, Spicer Z and Millhorn DE: Bcl-2/adenovirus E1B 19 kDa interacting protein-3 knockdown enables growth of breast cancer metastases in the lung, liver, and bone. Cancer Res 65: 11689-11693, 2005.
24. Barault L, Veyrie N, Jooste V, et al: Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers. Int J Cancer 122: 2255-2259, 2008.
25. Manning BD and Cantley LC: AKT/PKB signaling: Navigating downstream. Cell 129: 1261-1274, 2007.
26. Velho S, Oliveira C, Ferreira A, et al: The prevalence of PIK3CA mutations in gastric and colon cancer. Eur J Cancer 41: 1649-1654, 2005.
27. Benvenuti S, Frattini M, Arena S, et al: PIK3CA cancer mutations display gender and tissue specificity patterns. Hum Mutat 29: 284-288, 2008.
28. Abubaker J, Bavi P, Al-Harbi S, et al: Clinicopathological analysis of colorectal cancers with PIK3CA mutations in Middle Eastern population. Oncogene 27: 3539-3545, 2008.
29. Nosho K, Kawasaki T, Ohnishi M, et al: PIK3CA mutation in colorectal cancer: relationship with genetic and epigenetic alterations. Neoplasia 10: 534-541, 2008.
30. Samuels Y, Diaz LA Jr, Schmidt-Kittler O, et al: Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell 7: 561-573, 2005.
31. Ogino S, Nosho K, Kirkner GJ, et al: PIK3CA mutation is associated with poor prognosis among patients with curatively resected colon cancer. J Clin Oncol 27: 1477-1484, 2009.
32. Nosho K, Yamamoto H, Takahashi T, et al: Genetic and epigenetic profiling in early colorectal tumors and prediction of invasive potential in pT1 (early invasive) colorectal cancers. Carcinogenesis 28: 1364-1370, 2007.
33. Whitehall V, Rickman C, Bond C, et al: Oncogenic PIK3CA mutations in colorectal cancers and polyps. Int J Cancer: 2011 (Epub ahead of print) doi:10.1022/ijc.26440
34. Bruin SC, He Y, Mikolajewska-Hanclich I, et al: Molecular alterations associated with liver metastases development in colorectal cancer patients. Br J Cancer 105: 281-287, 2011.